Comparing the effects of high-dose vitamin E with those of placebo on insulin schizophrenia treated with olanzapine

Journal of Clinical Psychopharmacology

Volumn 29, Issue 2, 2009, Pages 182-183

  Salmasi, Fiona Baroyant ^a   Jazayeri, Maryam ^a   Ghaeli, Padideh ^b   Hashemian, Farshad ^a   Akhondzadeh, Shahin ^b   Raisi, Firoozeh ^b   Hosseini, Seyed Hamzeh ^c   Setareh, Mohammad Javad ^c   Khavidaki, Simin Dashti ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; OLANZAPINE; PLACEBO;

DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION;

ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OXIDATIVE STRESS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 67649369290     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819a6aa2     Document Type: Letter

References (10)

1. Sernyak MJ, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002;159:561-566.
2. Hedenmalm K, Hagg S, Stahl M, et al. Glucose intolerance with atypical antipsychotics. Drug Saf. 2002;25:1107-1116.
3. Kornegay CJ, Vasilakis-Scaramozza C, Jick H. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database. J Clin Psychiatry. 2002;63:758-762.
4. Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res. 1996;19:1-17.
5. Tylec A, Jarzab A, Stryjecka-Zimmer M, et al. Stress oxidative in schizophrenia. Pol Merkur Lekarski. 2007;23:74-77.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
7. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
8. Koro CE, Fedder DO, L'Italien GJ, et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ. 2002;325:243-247.
9. Ostbye T, Curtis LH, Masselink LE, et al. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2005;14:407-415.
10. Jain SK, McVie R, Jaramillo JJ, et al. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients. J Am Col l Nutr. 1996;15:458-461.